Panorama

Thelo Aasgaard on his way to Anderlecht, Tobe Leysen undergoing medical tests

Anderlecht is focusing on Thelo Aasgaard for reinforcement, while Tobe Leysen is undergoing medical tests at KRC Genk.

2 September 2026Tagblick Newsdesk

AI-generatedWritten by an AI system, editorially responsible — how we work

Archive photo: Thelo Aasgaard on his way to Anderlecht, Tobe Leysen undergoing medical tests — Archive photoPhoto: Werner100359 · Wikimedia Commons · CC BY-SA 4.0

Anderlecht has turned its attention to Thelo Aasgaard from Rangers, as the club remains active in the transfer market searching for a midfielder. Aasgaard, 24, is viewed as a potential addition to the team. This news has been confirmed by multiple sources, including Gazet van Antwerpen and Het Nieuwsblad, which highlight Anderlecht's interest in the player.

Additionally, Tobe Leysen will undergo medical tests at KRC Genk tomorrow morning. Leysen, a goalkeeper from Geel, appears close to returning to Genk after previous transfer negotiations fell through. This detail was reported by Het Nieuwsblad.

According to Het Nieuwsblad, there are also rumors regarding potential departing players at KRC Genk. The departure of Nikolas Sattlberger and a loan deal involving Robin Mirisola are currently being discussed, although no definitive decisions have been made.

The transfer window in Belgium remains open until September 3, giving clubs like Anderlecht and KRC Genk the opportunity to strengthen their squads. However, many European leagues have already closed their summer markets.

This item was written by an AI system on the basis of the headlines and short teasers of the independently operating newsrooms named below. We disclose this under Art. 50(4), second subparagraph, of Regulation (EU) 2024/1689 (AI Act). Before publication we check origin and verifiability — anything that appears in only one place is not published — as well as language, substance and legally sensitive content. No separate substantive review of each individual item by a natural person takes place; we therefore do not rely on the exemption in Art. 50(4), second subparagraph, of the AI Act. Editorial responsibility for this publication rests with the person named in the imprint (§ 18 Abs. 2 MStV). Please report errors to [email protected] — we will correct or remove the item. Full reports are available from the sources listed.